Leaflet PAMIRED 60mg lyophilisate for solution for intravenous infusion

Product code:
W56158001
Quantity:
1
Indicated for:
bone metastases; tumor-induced hypercalcemia
Route of administration:
infusion
Substance:
pamidronic acid (bisphosphonate)
ATC
M05BA03 — Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates

Precautions:

Take on an empty stomach

Take on an empty stomach

Take this medicine on an empty stomach.

Avoid milk, calcium, iron, or antacids

Avoid milk, calcium, iron, or antacids

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

Pamidronic acid is a bisphosphonate used to treat hypercalcemia associated with cancer and to prevent skeletal complications in patients with bone metastases. It works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone loss.

It is administered intravenously and is effective in lowering high calcium levels in the blood, which can occur in certain types of cancer. It is also used to reduce the risk of bone fractures and other complications in patients with bone metastases.

Common side effects include fever, flu-like symptoms, and bone or muscle pain. In rare cases, it may cause osteonecrosis of the jaw, especially in patients who have recently undergone dental procedures.

Patients receiving pamidronic acid treatment should be monitored for kidney function, as the drug can affect the kidneys, particularly at high doses.

General data about PAMIRED 60mg

Substance:
pamidronic acid
Date of latest medicines list:
01-10-2013
Product code:
W56158001
Concentration:
60mg
Pharmaceutical form:
lyophilisate for solution for intravenous infusion
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for pamidronic acid

  • 15mg
  • 15mg/ml
  • 30mg
  • 3mg/ml
  • 60mg
  • 6mg/ml
  • 9mg/ml